Malaysian biotech park expects major investments in three years
Play
Malaysian Biotechnology Corp (BiotechCorp) expects the pharmaceutical technology park in Alor Gajah, Malacca, to attract 1.5 billion ringgit (Bt15 billion) in investments in the next three years. BiotechCorp chief executive officer Mohammed Nazleen Kamal
“This will be the first pharmaceutical park in Malaysia to support the country's bio-economy initiative,” he said after the exchange of documents for a biomedical partnership with DRB-Hicom Bhd and two other parties to develop the park. He said the first phase of the park consisted of 81 hectares, with construction expected to start by the fourth quarter next year or the first quarter of 2014.
